Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT01669928
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 103 participants
- Registry
-
NCT01669928
-
- Other papers using this trial's data
- Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood Pressure
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Greece, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01669928. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2015-07 (actual). Results posted on 2021-03-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
- Acronym
- HARMONY
- Condition
- Hypertension
- Intervention (Drug)
- Anti-hypertensive Medication -
- Lead sponsor
- Imperial College London
- Collaborator
- Aristotle University Of Thessaloniki
Record details
- Record id
cardio:ct-nct01669928- Content hash
c1fd8688c44bc6a23581f7ed8e3cf1713eaf5d9f34b45e2925aaab802772956c